BRIEF-Valeant pharmaceuticals says invests in Canadian operations

Fri Jun 17, 2016 8:22am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 17 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant Pharmaceuticals announces significant investments in Canadian operations

* $12.5 million investment in Laval, Quebec facility and transfer of Arestin  production

* $15 million investment in Steinbach, Manitoba facility and transfer of Xifaxan  and Apriso  production

* Valeant Canada expanding Canadian manufacturing, export capacity with investments totaling $27.5 million

* $15 million investment includes $7 million in upgrades to product manufacturing technology

* $15 million investment also includes $8 million for transfer of North American production of Xifaxan (rifaximin) and Apriso Source text for Eikon: Further company coverage: